Glioma in 2014: unravelling tumour heterogeneity-implications for therapy
- PMID: 25560529
- DOI: 10.1038/nrclinonc.2014.223
Glioma in 2014: unravelling tumour heterogeneity-implications for therapy
Abstract
Heterogeneity within and across tumours is increasingly recognized as a critical factor that limits therapeutic progress for many cancers. Key studies reported in 2014 describe previously unappreciated patterns of geographical and temporal heterogeneity for glioblastoma (the most-common primary CNS tumour in adults), with important implications for ongoing therapeutic studies evaluating molecular targeted therapies.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
